Mia Md Tofayel Gonee Manik

Mr. Mia Md Tofayel Gonee Manik

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2023 in Journal of Ecohumanism
Verified
Journal Article
Open access
PDF file
MMMia Md Tofayel Gonee Manik
Mia Md Tofayel Gonee Manik
A complicated and diverse neurological condition, ischemic stroke (IS) is marked by a high death rate and substantial long-term impairment. Despite extensive research, reliable biomarkers for the clinical diagnosis and prognosis of ischemic stroke remain elusive, and the underlying molecular pathways remain obscure. This study uses a physiologically informed Convolutional Neural Network (BioCNN) to integrate multi-omics and present a novel method for the early identification and classification of ischemic stroke subtypes. Multi-omics Thirty acute ischemic stroke patients who were hospitalized within twenty-four hours after the beginning of symptoms provided data. Multi-omics profiling included mRNA, miRNA, circRNA, and DNA methylation datasets. After rigorous preprocessing, the integrated into a biomedical knowledge graph to enable graph-based learning. The BioCNN model outperformed models based on individual omics layers in terms of prediction performance. Its accuracy was 97.89%, its F1-score was 96.48%, and its AUC was 95.12%. Comparative analyses also revealed that among single-omics models, mRNA data yielded the best results, highlighting the complementary value of multi-omics integration. These findings emphasize the effectiveness of deep learning frameworks combined with integrated multi-omics data for advancing biomarker discovery and accurate classification of ischemic stroke subtypes, offering promising implications for early diagnosis and personalized treatment strategies.

23 January 2025 in Frontiers in Bioscience-Elite
Verified
Journal Article
Open access
PDF file
MBMohammad Muzahidur Rahman Bhuiyan
Mohammad Muzahidur Rahman Bhuiyan
INInshad Rahman Noman
Inshad Rahman Noman
Munna AzizMunna Aziz
Munna Aziz
MRMd Mizanur Rahaman
Md Mizanur Rahaman
MIMD Rashedul Islam
MD Rashedul Islam
Kallol DasKallol Das
Kallol Das
Our study focused on plant breeding, from traditional methods to the present most advanced genetic and data-driven concepts. Conventional breeding techniques, such as mass selection and cross-breeding, have been instrumental in crop improvement, although they possess inherent limitations in precision and efficiency. Advanced molecular methods allow breeders to improve crops quicker by more accurately targeting specific traits. Data analytics and information technology (IT) are crucial in modern plant breeding, providing tools for data management, analysis, and interpretation of large volumes of data from genomic, phenotypic, and environmental sources. Meanwhile, emerging technologies in machine learning, high-throughput phenotyping, and the Internet of Things (IoT) provide real-time insights into the performance and responses of plants to environmental variables, enabling precision breeding. These tools will allow breeders to select complex traits related to yield, disease resistance, and abiotic stress tolerance more precisely and effectively. Moreover, this data-driven approach will enable breeders to use resources judiciously and make crops resilient, thus contributing to sustainable agriculture. Data analytics integrated into IT will enhance traditional breeding and other key applications in sustainable agriculture, such as crop yield improvement, biofortification, and climate change adaptation. This review aims to highlight the role of interdisciplinary collaboration among breeders, data scientists, and agronomists in absorbing these technologies. Further, this review discusses the future trends that will make plant breeding even more effective with this new wave of artificial intelligence (AI), blockchain, and collaborative platforms, bringing new data transparency, collaboration, and predictability levels. Data and IT-based breeding will greatly contribute to future global food security and sustainable food production. Thus, creating high-performing, resource-efficient crops will be the foundation of a future agricultural vision that balances environmental care. More technological integration in plant breeding is needed for resilient and sustainable food systems to handle the growing population and changing climate challenges.

13 April 2025 in Journal of Posthumanism
Verified
Journal Article
Open access
PDF file
UHUrmi Haldar
Urmi Haldar
GAGazi Touhidul Alam
Gazi Touhidul Alam
HRHabiba Rahman
Habiba Rahman
MMMd Alamgir Miah
Md Alamgir Miah
PCPartha Chakraborty
Partha Chakraborty
MMMia Md Tofayel Gonee Manik
Mia Md Tofayel Gonee Manik
Business analytics has undergone significant transformation because of artificial intelligence and machine learning evolution, which now fulfills a critical function in economic expansion and organizational decision-making operations. Organization within the United States economy utilizes Management Information Systems to gain AI-powered insights, which enhance productivity and optimize resources and market prediction accuracy. The research evaluates how AI analytics drive economic growth because they enhance predictions while reducing possible hazards and generate strategic decisions through data-based approaches. The research uses both quantitative data methods together with qualitative case studies to investigate the subject. A combination of secondary market data, business reports, and economic statistics undergoes ML algorithm analysis, which reveals economic patterns and correlations because of their impact on performance. The research obtains practical information and usage barriers from both business managers and policymakers by conducting structured interviews regarding their implementation experiences with AI-based economic decision systems. The paper examines three significant AI methods, including predictive analytics with natural language processing and deep learning, which are applied to business intelligence. Voluntary business analytics, which run on artificial intelligence systems, boost decision-making by generating instant analytic information and simplifying complicated economic analysis tasks. Organizations that integrate AI and MIS systems to build data-based strategies boost operational performance while gaining competitive markets and ensuring durable economic expansion. Organizations should resolve the integration challenges together with data privacy concerns and ethical issues. The research findings demonstrate why organizations need to adopt AI-based analytics systems for developing business resilience and economic innovation in the United States.

15 January 2025 in Journal of Posthumanism
Verified
Journal Article
Open access
PDF file
SIShafiqul Islam
Shafiqul Islam
MMMia Md Tofayel Gonee Manik
Mia Md Tofayel Gonee Manik
MMMohammad Moniruzzaman
Mohammad Moniruzzaman
ASAbu Saleh Muhammad Saimon
Abu Saleh Muhammad Saimon
SSSharmin Sultana
Sharmin Sultana
MAMd Kamal Ahmed
Md Kamal Ahmed
In this research, an advanced framework is presented which combines Explainable Artificial Intelligence (XAI), machine learning algorithms and knowledge representation techniques to improve personalized treatment recommendations in healthcare. Random Forest, XGBoost and Deep Neural Networks (DNN) are used in this study to predict optimal treatment plans; thereby, SHAP (Shapley Additive Explanations) and LIME (Local Interpretable Model-Agnostic Explanations) provides means of explaining models. A method is implemented, which uses knowledge graphs and SNOMED CT and UMLS ontologies for structuring patient data and disease-treatment relationships. Thus, the proposed framework is trained and tested on MIMIC-III and eICU Collaborative Research Database, utilizing over 50,000 patient records to assess its performance. The model performance is evaluated using accuracy, F1-score, AUC-ROC and SHAP scores to measure the model explain ability. Results show a 25% improvement in interpretability ratings of healthcare professionals and a 17.6% improvement in predictive accuracy from traditional AI models to state-of-the-art AI models. This study bridges representation gaps of AI driven recommendations and brings it closer to aid in clinical decision-making, improving transparency and trust in AI assisted healthcare. While integrating knowledge graphs and explainable AI techniques can help improve model performance and clinician adoption, using limited human insights to train AIs can perpetuate biased practices and institutions from linear AI. We will continue future research with real world clinical trials and further expand the framework to also utilize multi-institutional datasets for wider application.

15 January 2025 in Journal of Posthumanism
Verified
Journal Article
Open access
PDF file
MMMia Md Tofayel Gonee Manik
Mia Md Tofayel Gonee Manik
SMSraboni Clara Mohonta
Sraboni Clara Mohonta
FKFarhana Karim
Farhana Karim
MMMd Alamgir Miah
Md Alamgir Miah
SIShafiqul Islam
Shafiqul Islam
ASAbu Saleh Muhammad Saimon
Abu Saleh Muhammad Saimon
The clinical use of artificial intelligence for precision medicine delivers transformative results in drug discovery through its combination of big data analytics and machine learning with genomic research. The traditional methods used in the drug discovery process are expensive to implement and take lengthy durations while failing to deliver customized therapy for patients. The advent of artificial intelligence now conducts fast genomic database analysis to find new drug aims and develop targeted medicine for individual patients. The application of ML algorithms enables researchers to make disease progression forecasts as well as identify drug effectiveness and potential adverse effects leading to improved outcomes for genomic drug discovery patients. The research discusses how deep learning and reinforcement learning models are applied to work with big genomic and biomedical information datasets. Data storage through cloud computing platforms together with high-performance computing systems allows precision medicine to scale and become more efficient. AI computational biology combined with clinical information enhances pharma research by optimally structuring drug reuse analysis and promoting new drug development processes. The use of artificial intelligence leads genomics-based drug discovery to a new direction through high efficiency and cost reduction and individual patient therapy delivery. Precision medicine based on AI and bioinformatics advancements push forward personal healthcare into the future despite ongoing obstacles such as data security problems and interpretation challenges and regulatory limitations.

25 April 2025 in Journal of Posthumanism
Verified
Journal Article
Open access
PDF file
MMMohammad Moniruzzaman
Mohammad Moniruzzaman
SIShafiqul Islam
Shafiqul Islam
SMSraboni Clara Mohonta
Sraboni Clara Mohonta
MAMuhammad Adnan
Muhammad Adnan
АCАsikur Rаhmаn Chy
Аsikur Rаhmаn Chy
MMMia Md Tofayel Gonee Manik
Mia Md Tofayel Gonee Manik
The high price opacity of the United States healthcare persistently weighs down on consumers, as evidenced by studies indicating that more than 65% of patients are surprised by the cost of the treatment after getting care. Finally, it provides a solution to enhanced ‘transparency’ and cost predictability leveraging big data technologies. The analysis of a dataset comprising of more than 5 million hospital billing records from more than 1,200 US hospitals, obtained from the Centers for Medicare & Medicaid Services (CMS) data, in this research helps analyze how big data strategies can improve price transparency. The study employs a data mining technique, regression analysis and visualization tools to quantify price discrepancies exceeding 300% for identical procedures between different regions. Both predictive analytics models were useful in consumer facing pricing tools and were able to predict average procedure costs with an average 92% accuracy. The results verify that big data can revolutionize the process of identifying pricing anomalies and informing regulatory strategies. However, one of the challenges present today is the lack of standardization of data and interoperability. This dissertation presents a scalable framework for bringing big data into national healthcare pricing systems that better advance transparency, equity, and consumer trust.